Literature DB >> 23955558

Characterisation and evaluation of paramagnetic fluorine labelled glycol chitosan conjugates for (19)F and (1)H magnetic resonance imaging.

Elena De Luca1, Peter Harvey, Kirsten H Chalmers, Anurag Mishra, P Kanthi Senanayake, J Ian Wilson, Mauro Botta, Marianna Fekete, Andrew M Blamire, David Parker.   

Abstract

Medium molecular weight glycol chitosan conjugates have been prepared, linked by an amide bond to paramagnetic Gd(III), Ho(III) and Dy(III) macrocyclic complexes in which a trifluoromethyl reporter group is located 6.5 Å from the paramagnetic centre. The faster relaxation of the observed nucleus allows modified pulse sequences to be used with shorter acquisition times. The polydisperse materials have been characterised by gel permeation chromatography, revealing an average molecular weight on the order of 13,800 (Gd), 14,600 (Dy) and 16,200 (Ho), consistent with the presence of 8.5, 9.5 and 13 complexes, respectively. The gadolinium conjugate was prepared for both a q = 1 monoamide tricarboxylate conjugate (r1p 11.2 mM(-1) s(-1), 310 K, 1.4 T) and a q = 0 triphosphinate system, and conventional contrast-enhanced proton MRI studies at 7 T were undertaken in mice bearing an HT-29 or an HCT-116 colorectal tumour xenograft (17 μmol/kg). Enhanced contrast was observed following injection in the tail vein in tumour tissue, with uptake also evident in the liver and kidney with a tumour-to-liver ratio of 2:1 at 13 min, and large amounts in the kidney and bladder consistent with predominant renal clearance. Parallel experiments observing the (19)F resonance in the holmium conjugate complex using a surface coil did not succeed owing to its high R2 value (750 Hz, 7 T). However, the fluorine signal in the dysprosium triphosphinate chitosan conjugate [R1/R2 = 0.6 and R1 = 145 Hz (7 T)] was sharper and could be observed in vivo at -65.7 ppm, following intravenous tail vein injection of a dose of 34 μmol/kg.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955558     DOI: 10.1007/s00775-013-1028-y

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  16 in total

1.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

Authors:  P Caravan; J J Ellison; T J McMurry; R B Lauffer
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Paramagnetic 19F chemical shift probes that respond selectively to calcium or citrate levels and signal ester hydrolysis.

Authors:  Peter Harvey; Kirsten H Chalmers; Elena De Luca; Anurag Mishra; David Parker
Journal:  Chemistry       Date:  2012-06-11       Impact factor: 5.236

3.  Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance.

Authors:  Kirsten H Chalmers; Mauro Botta; David Parker
Journal:  Dalton Trans       Date:  2010-12-03       Impact factor: 4.390

4.  Design principles and theory of paramagnetic fluorine-labelled lanthanide complexes as probes for (19)F magnetic resonance: a proof-of-concept study.

Authors:  Kirsten H Chalmers; Elena De Luca; Naomi H M Hogg; Alan M Kenwright; Ilya Kuprov; David Parker; Mauro Botta; J Ian Wilson; Andrew M Blamire
Journal:  Chemistry       Date:  2010-01-04       Impact factor: 5.236

5.  Experimental measurement and theoretical assessment of fast lanthanide electronic relaxation in solution with four series of isostructural complexes.

Authors:  Alexander M Funk; Pascal H Fries; Peter Harvey; Alan M Kenwright; David Parker
Journal:  J Phys Chem A       Date:  2013-01-24       Impact factor: 2.781

Review 6.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

7.  Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Authors:  Taehwan Nam; Sangjin Park; Seung-Young Lee; Kyeongsoon Park; Kuiwon Choi; In Chan Song; Moon Hee Han; James J Leary; Simseok Andrew Yuk; Ick Chan Kwon; Kwangmeyung Kim; Seo Young Jeong
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

8.  Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.

Authors:  So Jin Lee; Heebeom Koo; Dong-Eun Lee; Solki Min; Seulki Lee; Xiaoyuan Chen; Yongseok Choi; James F Leary; Kinam Park; Seo Young Jeong; Ick Chan Kwon; Kwangmeyung Kim; Kuiwon Choi
Journal:  Biomaterials       Date:  2011-03-03       Impact factor: 12.479

9.  Fluorine (19F) MRS and MRI in biomedicine.

Authors:  Jesús Ruiz-Cabello; Brad P Barnett; Paul A Bottomley; Jeff W M Bulte
Journal:  NMR Biomed       Date:  2010-09-15       Impact factor: 4.044

10.  Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.

Authors:  Yoen Ju Son; Jin-Sung Jang; Yong Woo Cho; Hesson Chung; Rang-Won Park; Ick Chan Kwon; In-San Kim; Jae Yong Park; Sang Bong Seo; Chong Rae Park; Seo Young Jeong
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

View more
  10 in total

1.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

2.  Fluorous-Soluble Metal Chelate for Sensitive Fluorine-19 Magnetic Resonance Imaging Nanoemulsion Probes.

Authors:  Amin Haghighat Jahromi; Chao Wang; Stephen R Adams; Wenlian Zhu; Kazim Narsinh; Hongyan Xu; Danielle L Gray; Roger Y Tsien; Eric T Ahrens
Journal:  ACS Nano       Date:  2018-12-07       Impact factor: 15.881

Review 3.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

Review 4.  19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Authors:  Yanan Li; Jing Cui; Chenlong Li; Huimin Zhou; Jun Chang; Omer Aras; Feifei An
Journal:  ChemMedChem       Date:  2022-01-12       Impact factor: 3.540

5.  Single (19)F probe for simultaneous detection of multiple metal ions using miCEST MRI.

Authors:  Amnon Bar-Shir; Nirbhay N Yadav; Assaf A Gilad; Peter C M van Zijl; Michael T McMahon; Jeff W M Bulte
Journal:  J Am Chem Soc       Date:  2014-12-22       Impact factor: 15.419

6.  The application of chiroptical spectroscopy (circular dichroism) in quantifying binding events in lanthanide directed synthesis of chiral luminescent self-assembly structures.

Authors:  Oxana Kotova; Salvador Blasco; Brendan Twamley; John O'Brien; Robert D Peacock; Jonathan A Kitchen; Miguel Martínez-Calvo; Thorfinnur Gunnlaugsson
Journal:  Chem Sci       Date:  2014-10-10       Impact factor: 9.825

7.  A new paramagnetically shifted imaging probe for MRI.

Authors:  P Kanthi Senanayake; Nicola J Rogers; Katie-Louise N A Finney; Peter Harvey; Alexander M Funk; J Ian Wilson; Dara O'Hogain; Ross Maxwell; David Parker; Andrew M Blamire
Journal:  Magn Reson Med       Date:  2016-02-28       Impact factor: 4.668

Review 8.  Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging.

Authors:  Katie L Peterson; Kriti Srivastava; Valérie C Pierre
Journal:  Front Chem       Date:  2018-05-23       Impact factor: 5.221

9.  Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging.

Authors:  Lina A Basal; Matthew D Bailey; Jonathan Romero; Meser M Ali; Lyazat Kurenbekova; Jason Yustein; Robia G Pautler; Matthew J Allen
Journal:  Chem Sci       Date:  2017-10-26       Impact factor: 9.825

10.  Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging.

Authors:  Alexander A Kislukhin; Hongyan Xu; Stephen R Adams; Kazim H Narsinh; Roger Y Tsien; Eric T Ahrens
Journal:  Nat Mater       Date:  2016-03-14       Impact factor: 43.841

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.